Sign in
4

Changes in Ownership

Odyssey Health, Inc. Filed Acc 0001683168-22-004341

VP of Drug Development acquired 1,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
VANLANDINGHAM JACOB PH.D VP of Drug Development 2022-06-10 Grant or award +1,000,000 $0.23 $230,000 9,660,000 I
Loading xslF345X03/ownership.xml…